Pregnancy-associated
breast cancer is defined as a
diagnosis of
breast cancer during
pregnancy or within 1 year of
childbirth. Current evidence shows that
Pregnancy-associated
breast cancer is associated with poor
prognosis; however, no
systematic review has summarized and explored how baseline characteristics could impact
survival. We aimed to explore the impact of
breast cancer characteristics on
death and
disease relapse. A
systematic review with meta-analyses was conducted by searching articles in the main databases (
Medline, Embase, and Cochrane) and
congress abstracts. Summarized
death and
disease-free survival hazard ratios were recalculated, and all meta-analyses used a random-effects model. Heterogeneity was reported using the I2
method. A total of 7143 studies were identified and only 30 studies were included.
Pregnancy-associated
breast cancer is associated with a 96% (HR 1.96; 95%CI 1.582.35) higher
risk of
death and 82% (HR 1.82; 95%CI 1.452.20)
risk of
death or
disease relapse in comparison to a
population of non-
pregnancy-associated
breast cancer or nulliparous
breast cancer. Through
sensitivity analyses, we identified that clinical outcomes were impacted, possibly due to Ki-67 levels, poorly differentiated
tumors, and
triple-negative breast cancer frequency in the study. As relevant sources of inconsistencies, such clinical
cancer-related characteristics should be better investigated as potential confounders for upcoming
Pregnancy-associated
breast cancer therapeutic strategies.